Ablation of Sptlc1 in EC reduces SL content in both EC and non-EC cell population of the lung.(A) Scheme of lung EC and non-EC isolation procedure used in this figure. (B) Representative flow cytometry analysis for determination of lung non-EC and EC population purities. Non-EC is identified as C...
more
Ablation of Sptlc1 in EC reduces SL content in both EC and non-EC cell population of the lung.(A) Scheme of lung EC and non-EC isolation procedure used in this figure. (B) Representative flow cytometry analysis for determination of lung non-EC and EC population purities. Non-EC is identified as CD45+/-; CD31- cells (Q1 + Q4). EC is identified as CD45-; CD31 + cells (Q3) (n=4 for both EC and non-EC). (C) EC and non-EC from Ctrl and Sptlc1 ECKO lungs were analyzed by Western Blotting for SPTLC1 and eNOS expressions. eNOS was used as an EC marker to demonstrate purity of each population. β-actin was used as an internal control. Relative fold change of SPTLC1 to Ctrl in EC and non-EC population were normalized to β-actin and quantified in (D) an (E) (n=3 for both genotypes). SL content in Ctrl and Sptlc1 KO EC was determined by LC-MS/MS, including dhC16-Cer, dhSph, dhS1P, Sph and S1P in (F), total Cer content in (G), and SM in (H) (n=5 for Ctrl EC, n=4 for Sptlc1 KO EC). SL content in Ctrl and Sptlc1 KO non-EC was determined by LC-MS/MS, including dhC16-Cer, dhSph, dhS1P, Sph, and S1P in (I), total Cer content in (J), and total SM content in (K) (n=5 for Ctrl non-EC, n=4 for Sptlc1 KO non-EC). Values of lipidomic results can be accessed in Figure 1—source data 1. Data are expressed as mean ± SD. Statistical significance was determined by unpaired t test. *p<0.05; **p<0.01. ***p<0.001. ns, non-significant.Figure 1—source data 1.Levels of dhC16-Cer, dhSph, dhS1P, Sph, S1P, Cer, and SM in lung EC and non-EC populations of Ctrl and Sptlc1 ECKO mice.Figure 1—source data 2.Original blots of EC and non-EC from Ctrl and Sptlc1 ECKO lungs.Levels of dhC16-Cer, dhSph, dhS1P, Sph, S1P, Cer, and SM in lung EC and non-EC populations of Ctrl and Sptlc1 ECKO mice.Original blots of EC and non-EC from Ctrl and Sptlc1 ECKO lungs.Sptlc1 ECKO mice exhibit similar body weight and blood chemistry as control mice.(A) Schematic diagram illustrates generation of Sptlc1 ECKO mice. (B) Body weight was measured at indicated time after tamoxifen injection in Ctrl and Sptlc1 ECKO mice (n=3 for Ctrl, n=3–4 for Sptlc1 ECKO). (C) Blood chemistry analysis was performed using Ctrl and Sptlc1 ECKO serum via VETSCAN VS2 Chemistry Analyzer (n=4 for Ctrl, n=3 for Sptlc1 ECKO). Statistical significance in (B) was determined by One way-ANOVA test. Statistical significance in (C) was determined by unpaired t test. Data are expressed as mean ± SD. ns, non-significant.SPTLC1 expressions are not affected in bone marrow of Sptlc1 ECKO mice.(A) Bone marrow cells isolated from Ctrl and Sptlc1 ECKO mice were analyzed by western blotting for SPTLC1 expressions. β-actin was used as an internal control (n=3 for Ctrl, n=3 for Sptlc1 ECKO). (B) Relative fold change to Ctrl samples was quantified. Statistical significance was determined by unpaired t test. Data are expressed as mean ± SD. ns, non-significant.Figure 1—figure supplement 2—source data 1.Original blots of lysates from Ctrl and Sptlc1 ECKO bone marrows.Original blots of lysates from Ctrl and Sptlc1 ECKO bone marrows.Cer and SM are reduced in Sptlc1 KO EC while they are mildly affected in non-EC.(A) Lung EC Cer with different chain lengths in Ctrl and Sptlc1 ECKO mice were measured by LC-MS/MS (n=5 for Ctrl EC, n=4 for Sptlc1 KO EC). (B) Lung EC SMs with different chain lengths in Ctrl and Sptlc1 ECKO mice were measured by LC-MS/MS (n=5 for Ctrl EC, n=4 for Sptlc1 KO EC). (C) Lung non-EC Cer with different chain lengths in Ctrl and Sptlc1 ECKO mice were measured by LC-MS/MS (n=5 for Ctrl non-EC, n=4 for Sptlc1 KO non-EC). (D) Lung non-EC SMs with different chain lengths in Ctrl and Sptlc1 ECKO mice were measured by LC-MS/MS (n=5 for Ctrl non-EC, n=4 for Sptlc1 KO non-EC). Statistical significance was determined by unpaired t test. Data are expressed as mean ± SD. *p<0.05. **p<0.01. ***p<0.001. ns, nonsignificant.eNOS expressions and phosphorylation of eNOS are not affected in Sptlc1 KO EC.(A) Lung EC isolated from Ctrl and Sptlc1 ECKO mice were analyzed by Western Blotting for eNOS, phospho-eNOS and SPTLC1 expressions. β-actin was used as an internal control (n=4 for Ctrl, n=4 for Sptlc1 ECKO). (B) Relative fold change to β-actin signal was quantified. Statistical significance was determined by unpaired t test. Data are expressed as mean ± SD. ns, non-significant.Figure 1—figure supplement 4—source data 1.Original blots of EC and non-EC from Ctrl and Sptlc1 ECKO lungs.Original blots of EC and non-EC from Ctrl and Sptlc1 ECKO lungs.
less